Drug Shortage Report for SANDOZ ZOLMITRIPTAN ODT

Last updated on 2024-09-09 History
Report ID 225976
Drug Identification Number 02362996
Brand name SANDOZ ZOLMITRIPTAN ODT
Common or Proper name ZOLMITRIPTAN ODT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ZOLMITRIPTAN
Strength(s) 2.5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 2ODT
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-04-23
Estimated end date 2025-05-02
Actual end date
Shortage status Actual shortage
Updated date 2024-09-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2024-09-09 French Compare
v10 2024-09-09 English Compare
v9 2024-07-22 French Compare
v8 2024-07-22 English Compare
v7 2024-06-12 French Compare
v6 2024-06-12 English Compare
v5 2024-06-03 French Compare
v4 2024-06-03 English Compare
v3 2024-04-24 English Compare
v2 2024-04-23 French Compare
v1 2024-04-23 English Compare

Showing 1 to 11 of 11